Christos Miliotis

Christos Miliotis is a scientist, editor development at Verve Therapeutics with expertise in high-throughput lentiviral screening. Prior to joining Verve, he obtained his Ph.D. in Virology from Harvard Medical School, where he combined computational and CRISPR screening approaches to investigate the role of non-coding RNAs in cancer immunotherapy and viral replication. He received his BA in Natural Sciences, with a focus in Pathology, from the University of Cambridge in the UK.